Overview

Rifaximin in Patients With Gastroesophageal Variceal Bleeding

Status:
Completed
Trial end date:
2018-02-28
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of Rifaximin in the treatment of cirrhotic gastroesophageal variceal bleeding.
Phase:
N/A
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Rifamycins
Rifaximin